John T Curnutte's Net Worth
$8.36 Million
Who is John T Curnutte?
John T Curnutte has an estimated net worth of $8.36 Million. This is based on reported shares across multiple companies, which include PLIANT THERAPEUTICS, INC., Orchard Therapeutics plc, Diadexus, Inc., and PORTOLA PHARMACEUTICALS INC.
SEC CIK
John T Curnutte's CIK is 0001574589
Past Insider Trading and Trends
2015 was John T Curnutte's most active year for acquiring shares with 13 total transactions. John T Curnutte's most active month to acquire stocks was the month of December. 2015 was John T Curnutte's most active year for disposing of shares, totalling 19 transactions. John T Curnutte's most active month to dispose stocks was the month of May. 2017 saw John T Curnutte paying a total of $752,072.50 for 166,000 shares, this is the most they've acquired in one year. In 2017 John T Curnutte cashed out on 166,971 shares for a total of $4,396,460.32, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
PLIANT THERAPEUTICS, INC. (PLRX) Snapshot price: $16.1
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 29
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Orchard Therapeutics plc (ORTX) No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 17
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Diadexus, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
PORTOLA PHARMACEUTICALS INC No price found
EVP R&DJohn T Curnutte owns 101,656 units of Common Stock. From 2013 to 2019 John T Curnutte acquired a total of 325,924 shares in PORTOLA PHARMACEUTICALS INC at a cost of $1,899,989.00, John also disposed a total of 240,956 shares of PORTOLA PHARMACEUTICALS INC equalling to $10,264,392.80.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +3.16% | 3.12K |
$28.69 | -$95,279.49 | 101.66K |
Scheduled
|
May 17 - May 20
| ||
Form 4
| -6.14% | -6.45K |
$33.41 | -$215,360.86 | 98.54K |
Scheduled
|
Mar 4
| ||
Form 4
| +4.48% | 4.5K |
—
|
—
| 104.98K |
Jan 31
| |||
Form 4
| +1.04% | 1.03K |
$24.25 | -$17,338.75 | 100.48K |
Scheduled
|
Jan 12 - Jan 15
| ||
Form 4
| +9.31% | 8.62K |
$29.18 | -$259,203.14 | 101.2K |
Scheduled
|
Aug 31 - Sep 4
| ||
Form 4
| +9.26% | 9.33K |
$26.05 | -$212,854.55 | 110.08K |
Scheduled
|
Jul 28 - Aug 23
| ||
Form 4
| +2.64% | 3.04K |
$40.82 | -$67,230.54 | 118.25K |
Scheduled
|
May 22
| ||
Form 4
|
∞
| 5.05K |
$8.50 | $42,916.50 | 5.05K |
Mar 12
| |||
Form 4
| -16.76% | -4.53K |
$32.53 | -$147,360.90 | 22.5K |
Scheduled
|
Mar 2
| ||
Form 4
|
∞
| 8.75K |
—
|
—
| 8.75K |
Jan 31
| |||
Form 4
|
∞
| 21K |
$7.75 | $157,072.50 | 21K |
Sep 28
| |||
Form 4
| -100.00% | -2.64K |
$54.86 | -$145,049.84 |
0
|
Scheduled
|
Aug 16
| ||
Form 4
|
—
|
0
|
$36.75 | -$565,000.00 |
0
|
Scheduled
|
Jul 18
| ||
Form 4
|
—
|
0
|
$33.19 | -$2,962,955.01 |
0
|
Scheduled
|
Jun 26
| ||
Form 4
| -8.88% | -3.33K |
$38.61 | -$128,455.47 | 34.15K |
Scheduled
|
Mar 2
| ||
Form 4
|
∞
| 12.5K |
—
|
—
| 12.5K |
Jan 30
| |||
Form 4
|
∞
| 6.25K |
—
|
—
| 6.25K |
May 1
| |||
Form 4
| -12.71% | -1.27K |
$31.75 | -$40,354.25 | 8.73K |
Scheduled
|
Mar 2
| ||
Form 4
|
∞
| 10K |
—
|
—
| 10K |
Jan 27
| |||
Form 4
|
—
|
0
|
$29.25 | -$415,000.00 |
0
|
Scheduled
|
Jul 15
| ||
Form 4
|
—
|
0
|
$28.00 | -$390,000.00 |
0
|
Scheduled
|
Jun 22
| ||
Form 4
|
—
|
0
|
$26.75 | -$365,000.00 |
0
|
Scheduled
|
Jun 16
| ||
Form 4
|
—
|
0
|
$25.50 | -$340,000.00 |
0
|
Scheduled
|
May 29
| ||
Form 4
|
—
|
0
|
$24.40 | -$317,980.00 |
0
|
Scheduled
|
May 28
| ||
Form 4
|
—
|
0
|
$24.25 | -$315,000.00 |
0
|
Scheduled
|
Feb 23
| ||
Form 4
|
—
|
0
|
$23.00 | -$290,000.00 |
0
|
Scheduled
|
Feb 18
| ||
Form 4
|
—
|
0
|
$21.75 | -$265,000.00 |
0
|
Scheduled
|
Feb 17
| ||
Form 4
|
—
|
0
|
$20.50 | -$240,000.00 |
0
|
Scheduled
|
Feb 13
| ||
Form 4
|
∞
| 10K |
—
|
—
| 10K |
Jan 27
| |||
Form 4
|
—
|
0
|
$18.42 | -$595,000.00 |
0
|
Scheduled
|
Jun 17 - Jun 18
| ||
Form 4
|
—
|
0
|
$17.25 | -$174,970.00 |
0
|
Scheduled
|
Jun 16
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 26
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||